Document is current
Any future updates will be listed below
-
Authors
Hegde, Manasa Manjunath
Goda, Jayant Sastri
Mutalik, Srinivas
Palkar, Pranoti
Mohanty, Bhabani Shankar
Chaudhari, Pradip
Sahay, Ayushi
Thorat, Rahul
Parashiva, Guruprasad Kanive
Rao, Bola Sadashiva Satish https://orcid.org/0000-0002-9631-9731
-
Funding
Funding for this research was provided by:
Manipal Academy of Higher Education, Manipal
- License Information
-
More Information
Article History
Received: 3 March 2025
Accepted: 9 December 2025
First Online: 22 December 2025
Declarations
:
: All animal experiments were performed with prior approval from the Institutional Animal Ethics Committee (IAEC) Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Mumbai, India (IAEC Approval no. IAEC/07/22). The IAEC of the ACTREC-TMC, Registration no. 65/GO/ReBiBt/S/99/CPCSEA approved the protocol. Animal care and handling was done according to the guidelines of the World Health Organization and the Indian National Science Academy, New Delhi, India ( ). Homozygous BALB/c Nude Mice ( Mus musculus ) aged 6 weeks and weighing 29 ± 4 g were used for all experimental procedures and were housed and maintained in the laboratory animal facility of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) at the Tata Memorial Centre (TMC).
: B. S. Satish Rao reports that the India Ministry of Science & Technology Department of Science and Technology provided financial support. B. S. Satish Rao has patent “Active Agent(s) Loaded Multifunctional Lipidic Nanovesicles for Glioblastoma Therapy and the Method of Preparation Thereof” having application No. 202341064267 pending to Manipal Academy of Higher Education. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
